logo

For the Inventor, By the Inventor

Irvington, NY, United States of America

Saul J Silverstein

USPTO Granted Patents = 10 

Average Co-Inventor Count = 3.3

ph-index = 7

Forward Citations = 1,724(Granted Patents)


Location History:

  • Irvington, NY (US) (1983 - 2004)
  • New York, NY (US) (2007)

Company Filing History:

goldMedal10 out of 2,488 
 
Columbia University
 patents

Years Active: 1983-2007

Loading Chart...
10 patents (USPTO):Explore Patents
1. 7273616 - [object Object] (2007-09-25),
2. 6809182 - VZV ORF29p protein-related compositions and methods (2004-10-26),
3. 6756368 - Use of cobalt chelates for treating or preventing virus infection (2004-06-29),
4. 6455275 - DNA construct for producing proteinaceous materials in eucaryotic cells (2002-09-24),
5. 5888724 - Detection of high oncogenic-risk papilloma virus in high grade cervical (1999-03-30),
6. 5814448 - Polymerase chain reaction/restriction fragment polymorphism method for (1998-09-29),
7. 5543294 - Polymerase chain reaction/restriction fragment length polymorphism (1996-08-06),
8. 5179017 - Processes for inserting DNA into eucaryotic cells and for producing (1993-01-12),
9. 4634665 - Processes for inserting DNA into eucaryotic cells and for producing (1987-01-06),
10. 4399216 - Processes for inserting DNA into eucaryotic cells and for producing (1983-08-16),

Title: The Innovative Contributions of Saul J. Silverstein

Introduction

Saul J. Silverstein is a prominent inventor based in Irvington, NY (US), known for his significant contributions to the field of biotechnology. With a total of 10 patents to his name, he has made remarkable advancements in the development of genetically engineered cell lines and vaccines.

Latest Patents

Among his latest patents, one invention provides genetically engineered cell lines, recombinant vectors, and vaccines. This invention also outlines methods for generating an in vitro system for Varicella zoster virus (VZV) and the systems produced by these methods. Furthermore, it includes methods for reactivating VZV and the VZV reactivated by these methods. Another notable patent focuses on VZV ORF29p protein-related compositions and methods. This invention offers compositions comprising 29p protein bound to an agent intended for delivery into a eukaryotic cell. It also introduces a monoclonal antibody that specifically binds to 29p protein, along with methods for delivering agents into eukaryotic cells and causing them to secrete desired proteins in the form of fusion proteins. Additionally, it provides pharmaceutical compositions containing 29p protein and nucleic acid molecules that hybridize to portions of nucleic acid encoding 29p protein.

Career Highlights

Saul J. Silverstein has had a distinguished career, primarily associated with Columbia University, where he has conducted extensive research and development in his field. His work has significantly impacted the understanding and treatment of viral infections.

Collaborations

Throughout his career, Saul has collaborated with notable scientists, including Richard Axel and Michael H. Wigler, contributing to various innovative projects and research initiatives.

Conclusion

Saul J. Silverstein's contributions to biotechnology and his innovative patents have paved the way for advancements in medical science. His work continues to influence the development of effective treatments for viral infections, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…